Company intelligence / Profile preview
TotipotentRX
Irvine, California, United Statestotipotentrx.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
TotipotentRX developed autologous cell therapies using proprietary point-of-care platforms. It published positive Phase I/II data in critical limb ischemia (~40 months follow-up), received FDA acceptance for a Phase III trial design, demonstrated safety/feasibility of autologous PRP for chronic ulcers and bone marrow mononuclear cells for cardiac repair. In later years its clinical assets were spun off into ImmuneCyte Inc after acquisition by ThermoGenesis.
- Therapeutic areas
- CardiovascularRheumatologyOphthalmologyEndocrinologyDermatology
- Modalities
- Cell therapyPlatelet-rich plasma therapyAutologous bone marrow mononuclear cell therapyBiologicMesenchymal stem cell therapy
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Exclusive provider of cell-based products/services to Fortis Healthcare System at time of merger announcement.
Beyond the preview
Go deeper on TotipotentRX.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TotipotentRX.